Home / CATEGORY / Pharma Healthcare

Categories
Pharma Healthcare

Home healthcare refers to the supportive and cost-effective medical assistance received at home for any kind of illness or injury. Market Insights: In 2019, the market accounted for approximately 4% of India?s overall healthcare industry earnings. It was valued at INR 460.00 Bn in 2020. It is expected to reach INR 3,228.19 Bn by 2026, expanding at a compound annual growth rate (CAGR) of ~38.59% during the 2021 ? 2026 period. An increase in the size of the aging population and the increased prevalence of chronic ailments such as hypertension, diabetes, arthritis, cancer, and cardiovascular diseases are aiding the growth of the market. The government is trying to motivate patients to reduce hospital visits and avail home-care services through its healthcare initiative, Ayushman Bharat Scheme (Union Budget 2019). This will propel market growth. Competition is intense because of the presence of existing players and the entry of new digital healthcare firms (such as Netmeds, 1MG, and Myra), who are expanding their portfolios for home healthcare services. Segment Insights: The market is broadly segmented into home healthcare services, devices, and solutions. In 2020, home healthcare services was the largest segment, accounting for ~51.29% of the total market revenue. During the 2021 ? 2026 period, home healthcare solutions is expected to become the fastest-growing segment of the market as a result of social distancing rules and self-isolation norms that are in place to curb the spread of COVID-19. By 2026, the home healthcare devices and home healthcare solution segments are expected to hold ~19.15% and ~41.60% shares, respectively, in terms of market revenue. COVID-19 Impact Analysis: The outbreak of COVID-19 in India and subsequent lockdowns to curb its spread severely impacted the home healthcare market in India. As the crisis continues, telehealth solutions, health screening and monitoring devices, and home nursing services segments are likely to witness significant growth. Social distancing norms, limited outdoor medical capacities, and initiatives undertaken by the Indian government to encourage at-home treatments and telehealth solutions are likely to accelerate market growth. Other home healthcare segments that may be affected favourably during this period include health diagnostic devices, at-home therapeutic services, and other medical supplies. ...

  • Id : RNR-881903
  • Category : Pharma Healthcare
  • Pages : 56

A part of the digital healthcare system, healthcare analytics provides enhanced health management services using IT and effective communication tools. It helps increase the efficiency of diagnosis and treatment. The growing demand for healthcare services on account of the COVID-19 pandemic drives the market. Some of the key players include domestic start-ups such as Qure.ai, Niramai Health Analytix Pvt. Ltd., SigTuple Technologies Pvt. Ltd., and Tricog Health India Pvt. Ltd. Foreign private companies such as IBM India Pvt. Ltd. and Microsoft Corporation India Pvt. Ltd. also operate in the market. Market insights: The healthcare analytics market was valued at INR 19.85 Bn in 2020. It is expected to reach INR 87.26 Bn by 2026, expanding at a compound annual growth rate (CAGR) of ~28.74% during the 2021 ? 2026 period. Both indigenous and global companies develop analytical solutions for healthcare. The surge in adoption of these solutions propel market growth. The government, healthcare providers, and pharmaceutical companies are the major end users. Medical data analytics is expected to reduce the patient death rate by using focused tools for diagnosis and planning out proper treatment procedures. Analytics use cases in healthcare: Healthcare providers and pharmacies use analytics for various purposes such as training, research, and detection, diagnosis, and treatment of illness. These applications are carried out with the help of three types of analytics ? descriptive, predictive, and prescriptive. Descriptive analytics is used to determine contagious levels of COVID-19 by examining the rate of positive test results in a specific population. COVID-19 impact analysis: In the wake of the pandemic, healthcare providers, professionals, and researchers employ artificial intelligence (AI), machine learning, and natural language processing to track, contain, and gain a comprehensive understanding of COVID-19. AI is used to predict the severity of the disease and identify at-risk populations. It is also utilized for detecting body temperature, contact tracing, and further investigation through mobile-based applications to determine infection levels. Analytics also help in efficiently monitoring violations of COVID-19 protocols and enforcing social distancing. Data collected with the help of analytics from various sources assist in predicting future trends of disease spread and infection rate, understanding the existing situations, and making several medical decisions to control the pandemic. ...

  • Id : RNR-881896
  • Category : Pharma Healthcare
  • Pages : 47

Market insights In the recent years, e-pharmacy emerged as a better and more convenient approach that addressed the issues faced by the consumers and provided superior customer solutions over its physical counterparts. The e-pharmacy market was valued at INR 50.71 Bn in 2020. It is estimated to reach INR 458.14 Bn by 2026, expanding at a compound annual growth rate (CAGR) of ~44.99% during the 2021 ? 2026 period. Segment insights: The market is categorized into two segments ? chronic and acute therapy. In 2020, the chronic therapy segment dominated the market, accounting for 63.42% of the revenue. It is expected to dominate during the forecast period. However, its market share is likely to decline to 53.92% in 2026. The acute therapy segment is forecast to achieve promising growth during the forecast period. Its market share is anticipated to increase from 36.58% in 2020 to 46.08% in 2026, expanding at a CAGR of 50.56% during the 2021 ? 2026 period. Consumers with chronic conditions require long-term treatment, and thus, have repeated need for medication. People prefer e-pharmacy platforms, owing to the availability of a wide range of medicines at discounted prices. Customers may increasingly prefer these platforms for managing acute ailments such as common cold in the coming years. Market insights: The market has gained traction in recent years; increased penetration of the internet and smartphones, prevalence of lifestyle disease, and government initiatives have fuelled its growth. Discounts impacting profitability, data breaches and cybercrime, pharmacovigilance and bottleneck in supply network are a few of the factors that impedes its development. Several start-ups, leading e-commerce companies, and traditional brick-and-mortar stores have entered the market attracted by its immense growth potential. In 2020, it witnessed the entry of major players such as Amazon, Reliance, and Tata. In June 10, 2021, Tata Digital bought the key e-pharmacy player, 1mg. In the same month, PharmEasy acquired 66% stake in Thyrocare. Impact of COVID-19: The COVID-19 pandemic has disrupted the nationwide healthcare system and severely impacted online pharmacy. With the onset of the second wave, e-commerce platforms such as e-pharmacy has developed more in this situation. The market witnessed huge spike in sales during the second wave. It is expected to rise again when the third wave hits. Creating alliance with local pharmacy retailers enabled key players to address the gaps in their last-mile deliveries. Also, measures such as collaborating with e-payment platforms were taken to ensure safe and convenient transactions thereby attracting cashbacks, discounts and COD options in remote areas as well which helped in getting attention of customers from rural areas as well. ...

  • Id : RNR-881893
  • Category : Pharma Healthcare
  • Pages : 76

Medical technology involves the use of technology to develop cure-based systems that are used in hospitals. The medical technology market comprises players supplying health devices and instruments, diagnostic equipment and reagents, bionics, implants, disposables, and consumables. India appeared to be a profitable destination to major global players, owing to increase in income levels, private sector participation in healthcare, an aging population, and growth of medical tourism. The market is at a nascent stage and fragmented, dependent on imports and limited capabilities for indigenous manufacturing. The rapidly evolving technology landscape, conducive financial mechanism, and governmental thrust through Make in India initiatives are projected to expedite market growth during the 2021 ? 2025 period. It is estimated to reach INR 1,674.63 Bn by 2025, expanding at a compound annual growth rate (CAGR) of ~22.75% during the forecast period. Major players in the market include Opto Circuits Limited, Philips India Limited, Siemens Limited, TTK Healthcare Limited, and Appasamy Associates. Impact of COVID-19 The pandemic has put an enormous burden on the market by creating a supply-demand gap. While the demand for personal protective equipment rose steeply, the supply side was massively constrained due to lockdown measures. The revenue fell sharply in the first quarter of FY 2021 due to a drop in sales volume for Non-COVID-19 items. The players adopted various strategies to boost production capacities, collect payment from creditors, and address the changing demand to maintain business. Market segment insights The market is segmented into instruments and appliances, diagnostic imaging, consumables and implants, and patient aids and others. The instruments and appliances segment dominated the market, accounting for 33.72% of the total revenue in 2020. Patient aids and others is expected to be the fastest-growing segment during the forecast period. Key growth drivers of the market ? An increase in demand for new applications has led to the growth of medical technology market. For instance, improved surgical techniques and new implant materials for joint replacement (e.g., hybrid replacement method used in hip replacement surgery) are factors driving the growth of the orthopedic segment ? In India, non-communicable diseases (NCDs) are a major health problem. Diseases including cancer, obesity, and diabetes are on the rise as a result of factors such as a sedentary lifestyle and high stress levels. By 2025, NCDs would account for 75% of the disease burden in India. The significant increase in non-communicable diseases is driving demand in some key segments of the medical technology Market Key deterrents to the growth of the market Shortage of healthcare professionals and infrastructure is a significant reason behind the under-penetration of the market. According to the World Bank, in 2019, India had only 0.9 physicians per 1,000 patients. Besides, the healthcare sector faces a significant challenge in terms of infrastructure. India has an estimated 1.1 beds per 1,000 people, which is far behind the 3.5 beds per 1,000 people suggested by the WHO (World Health Organization) for better health infrastructure. Companies covered ? Opto Circuits Limited ? Philips India Limited ? Siemens Limited ? TTK Healthcare Limited ? Appasamy Associates ? BPL Medical Technologies Private Limited ? Forus Health Private Limited ? Hindustan Syringes & Medical Devices Limited ? Nidhi Meditech Systems ? Trivitron Healthcare Private Limited ...

  • Id : RNR-881889
  • Category : Pharma Healthcare
  • Pages : 106

Plasma is a major component of the blood that plays an essential role in regulating bodily functions. It constitutes around 55% of the total volume of blood, and comprises more than 700 proteins and other substances. It is a major component used in the treatment of health problems such as haemophilia and autoimmune disorders. Improved diagnostic facilities and the prevalence of chronic diseases are major factors that have raised the demand for plasma-derived products. The blood plasma products market has been experiencing steady growth over the past few years. The market increased at a CAGR of 11.26% during the FY 2016 ? FY 2020 period and is expected to reach INR ~10.43 Bn by FY 2025. The immunoglobulin segment accounted for the major share of the market in 2020 and is projected to maintain its leading position during the forecast period. Major players operating in the market include Bharat Serums and Vaccines Ltd. (BSV), Intas Pharmaceuticals Ltd., PlasmaGen BioSciences Private Ltd., Serum Institute of India Private Ltd., and Zydus Takeda Healthcare Private Ltd. Impact of COVID-19 The pandemic in India increased the need for convalescent measures, therapies, and cures for the ailing public. COVID-19 outbreak has pushed scientists to experiment with plasma therapy on infected people with the virus. This COVID-19 crisis highlighted the need for a massive supply of blood plasma for convalescent measures and treatments. Besides, India is heavily dependent on imported plasma products. These products fulfil 90% of the domestic demand, giving rise to a massive gap between demand and supply. Market segment insights In FY 2020, the immunoglobulin segment held the highest share (~46.78%) of the overall market. Immunoglobulin is used to treat various blood disorders such as primary and secondary immune deficiencies, and inflammatory and autoimmune diseases. Based on end users, the hospital segment dominated the market in FY 2020. Clinics and other end users segments are expected to expand at a growth rate of ~17.90% and ~24.77%, respectively, during the FY 2021 ? FY 2025 period. Key growth drivers of the market ? The demand for plasma derivative-based therapies has picked up in the wake of the pandemic, propelling market growth. According to a research study published in Blood Medicine Journal in 2016, FIX replacement therapy that comprises plasma-derived protein was found to be successful in reducing bleeding and disability in case of hemophilia B. According to the annual global survey conducted by the World Federation of hemophilia, around 50% of the world's hemophilia population lives in India. Hemophilia is treated through factor replacement therapy, using clotting factor VIII for hemophilia A and clotting factor IX for hemophilia B ? Immunodeficiency can be caused by various chronic illnesses. Immunoglobulin, a crucial part of plasma protein, is used as first-line therapy to treat various immunologic, neurologic, and hematologic conditions. India has shown a remarkable improvement in patient care with Primary Immune Deficiencies (PIDs), and several centers of excellence in PIDs have emerged. Thus, an increase in the demand for immunoglobulin is fueling the growth of the market Key deterrents to the growth of the market Plasma derivative-based therapy is a cost-effective solution to develop human plasma products such as antibodies and proteins in the long run. It is an expensive procedure that involves the complicated process of collecting plasma, which requires a large workforce. The cost of plasmapheresis equipment, complex logistics, and donor compensation are very high. Apart from that, low availability of recovered plasma is another major challenge faced by plasma product manufacturers. Companies covered ? Bharat Serums and Vaccines Ltd. (BSV) ? Bioviz Technologies Private Ltd. ? Intas Pharmaceuticals Ltd. ? PlasmaGen BioSciences Private Ltd. ? Plasmatech Solutions Private Ltd. ? Reliance Life Sciences Private Ltd. ? Serum Institute of India Private Ltd. ? Taj Pharma India Ltd. ? Virchow Biotech Private Ltd. ? Zydus Takeda Healthcare Private Ltd. ...

  • Id : RNR-881887
  • Category : Pharma Healthcare
  • Pages : 64

The private healthcare delivery sector includes any healthcare services provided by an individual or group that is profitable and is not controlled or operated by the government. It plays a fundamental role in the Indian healthcare sector by serving around 79% of the urban and 72% of the rural population. In terms of revenue, the private healthcare delivery sector in India was valued at INR 11,197.43 Bn in 2019, and is estimated to reach INR 34,135.53 Bn by 2025, expanding at a CAGR of ~16.60% during the 2020 ? 2025 period. Segment insights: The private healthcare delivery sector has three major segments ? the private hospital sector, the private diagnostics sector, and the pharmacy retail sector. The private hospital sector was the largest segment, holding a market share of ~78.11% in 2019. The market share of the private diagnostics segment is estimated to increase sizeably to reach ~12.62% by 2025. The private hospital sector has witnessed significant growth over the past few years, backed by private equity investments. The major private hospitals in India are concentrated in urban and semi-urban areas. The players in the sector are focusing on expanding their network of super-specialty and multi-specialty hospitals in tier II and tier III cities in India. The private diagnostics sector is anticipated to exhibit a massive growth over the forecast period, on account of an increase in preventive healthcare and evidence-based treatment in India. The sector is largely fragmented and consists of hospital-based labs, standalone centers, and large diagnostic chains. Pharmacy retail was the second-leading segment of the private healthcare delivery sector in Indian in 2019. An increase in the patient pool of those suffering from chronic illnesses, coupled with better affordability, has driven the pharmacy retail segment. With the improved digital infrastructure of the country, the online pharmacy sub-segment is expected to create immense opportunities in the market. Impact of COVID-19: The pandemic has had a huge impact on the private healthcare delivery sector in terms of business operations and financial performance. The enforcement of the stringent lockdown led to a steep decline in the number of patients in private hospitals, as well as diagnostic centers. The cancellation of elective surgeries and the closure of outdoor patient departments have caused a sharp decrease in industry revenue. Furthermore, travel restrictions and the closure of inter-state borders created blockages in the supply chain and logistics. However, strategies, including digital transformation, capacity expansion, and increased collaborations with vendors have improved sustainability and aided the recovery of the sector. Companies covered: ? Apollo Hospitals Enterprise Ltd ? Dr. Lal PathLabs Ltd. ? Fortis Healthcare Ltd. ? HealthCare Global Enterprises Ltd. ? Max Healthcare Institute Ltd. ? Narayana Hrudayalaya Ltd. ? Shalby Ltd. ? Netmeds Marketplace Ltd. ? 1mg ? 91Streets Media Technologies Private Limited (PharmEasy) ...

  • Id : RNR-881873
  • Category : Pharma Healthcare
  • Pages : 96

The pharmacy retail market in India has witnessed significant growth in the past few years, owing to favorable demographic factors and an epidemiological change. In terms of revenue, the market was valued at INR 1,440.80 Bn in 2019 and is expected to reach INR 2,774.85 Bn by 2025, expanding at a compound annual growth rate (CAGR) of ~10.96% during the 2020 ? 2025 period. The market is dominated by unorganized local players. However, the unorganized sector is anticipated to face intense competition from organized players and online retailers. Segment insights: Based on the retail channel, the market is segmented into organized, unorganized, and online retail. The unorganized segment was the largest, holding a market share of ~92.06% in 2019. The share of the organized segment, which consists of licensed and registered players, is estimated to increase steadily during the forecast period. The online retail segment is estimated to expand at the fastest CAGR (~43.98%) during the 2020 ? 2025 period, owing to improved digital infrastructure. Based on the type of drugs, the market is segmented into generic, over the counter (OTC), and patented drugs. The generic drugs segment dominated the retail pharmacy market in India in 2019. It was followed by the OTC and patented drugs segments. The low price of generic drugs attributed to its leading share. The OTC drugs segment is anticipated to be the second-leading segment of the pharmacy retail market with a share of ~22.60% in 2025. Market influencers: Increased affordability, improved accessibility, and epidemiological transition are pivotal factors that have aided the growth of the pharmacy retail market in India. The rise in per capita income and penetration of health insurance coverage have enhanced consumers? affordability. A significant increase in the number of Indians covered under health insurance has helped propel consumer spending on pharmaceuticals. Pharmaceuticals have become more accessible, owing to the rise in public healthcare expenditure. This has fueled the growth of the pharmacy retail market, especially in rural areas and tier-II cities. A sluggish economy as a result of agrarian crisis, retail inflation, and lack of fiscal stimulants, has had a bearing on the profitability of the pharmacy retail market. Furthermore, uncertainty in drug pricing hinders market growth by way of impacting investors? sentiments. Impact of COVID-19: The pandemic impeded supply chain and logistics. Inter-state transportation was disrupted, so was the supply of raw materials from China. Online pharmacy, however, gained massive traction amid the pandemic. The lockdown encouraged the adoption of online pharmacy among consumers with chronic diseases, especially from tier II and tier III cities. Online retailers experienced surged orders and sales of pharmaceuticals, and embraced various growth strategies to meet the swelling demand. Several pharmacy retailers have adopted the click and mortar business model that has both online and offline presence, which typically includes a website and a physical store. Companies covered ? Apollo Pharmacies Limited ? Emami Frank Ross Limited ? Medlife ? MedPlus Health Services Private Limited ? Netmeds Marketplace Limited ? Noble Medichem Pvt Ltd. (Noble Plus) ? RWL Healthworld Limited (Fortis Health World) ? Wellness Forever Pharmacy ? 91Streets Media Technologies Private Limited (PharmEasy) ? 1mg...

  • Id : RNR-881872
  • Category : Pharma Healthcare
  • Pages : 56

Market insights Private hospitals play a pivotal role in the healthcare industry, providing healthcare services to more than 70% rural population and 80% urban population in India. In terms of revenue, the private hospital sector in India was valued at INR 7,557.84 Bn in 2019, and is estimated to reach INR 18,315.96 Bn by 2025, expanding at a compound annual growth rate (CAGR) of ~16.18% during the 2020-2025 period. Segment insights: The private hospital sector in India is segmented into self-pay, government payer, and corporate insurer. The self-pay segment was the largest in 2019, accounting for ~47.00% share of the overall market revenue. Corporate insurer is estimated to be the fastest-growing segment of the market, expanding at a CAGR of 21.47% during the 2020-2025 period. Increased public healthcare expenditure has resulted in the growth of the government payer segment. The penetration of medical insurance by corporate entities is likely to drive the corporate insurer segment. A rise in purchasing power, higher demand for quality healthcare, and expansion of the private hospital chain network has propelled the growth of corporate medical insurance. Market insights: Factors such as increased income, a rise in geriatric population, and an evolving disease profile have contributed to the sector's growth. The life expectancy of Indians has increased considerably, inciting more demand for healthcare services from the elderly population suffering from various degenerative diseases. On the other hand, the country experienced an epidemiological transition in the past few decades, with the shift from communicable to non-communicable diseases. The growing burden of lifestyle diseases has attracted demand for healthcare services from the private hospital sector. Furthermore, India's emergence as a preferred destination for medical tourists has stimulated the private hospital sector's growth. The sector encounters several restraining factors such as financial constraints, regulatory hurdles, and lack of skilled medical professionals. The market is highly capital intensive with a low and delayed return on investments. The sector faces financial challenges owing to reduced profit margin and a surge in operating expenditure. Furthermore, regulatory headwinds and the shortage of experienced healthcare professionals result in significant challenge for market players. Impact of COVID-19: The pandemic has disrupted the private hospital sector in India, negatively impacting patient footfall, hospital occupancy rate, and revenue. Various private hospitals have paused operations in the non-emergency and outdoor patient department (OPD) due to lockdown and fear of infection. The cancellation of elective surgeries and a sharp drop in the arrival of medical tourists led to poor revenue generation from indoor patient department (IPD) services. The decline in patient footfall in OPD and patient admission in IPD had intensified the financial distress of the private hospital sector, which was already burdened with low-profit margin and high costs. According to the Federation of Indian Chambers of Commerce and Industry (FICCI), the sector witnessed a drop in revenue of around 50% and a fall in EBITDA by nearly 60%, in the last week of March 2020. Companies covered ? Apollo Hospitals Enterprise Ltd ? Aster DM Healthcare Ltd. ? Fortis Healthcare Ltd. ? HealthCare Global Enterprises Ltd. ? Max Healthcare Institute Ltd. ? Narayana Hrudayalaya Ltd. ? Shalby Ltd. ? Columbia Asia Hospitals Pvt. Ltd. ? Manipal Health Enterprises Pvt. Ltd. ? Medanta The Medicity...

  • Id : RNR-881866
  • Category : Pharma Healthcare
  • Pages : 76

The traditional pharmacy retailing system face challenges such as counterfeit medicines, poor inventory management, limited brand tracking, and lack of documentation. E-pharmacy emerged as a safe and convenient interface that can address these issues and offer better customer experience. In terms of revenue, the e-pharmacy market in India was valued at INR 35.21 Bn in 2019, and is estimated to reach INR 313.80 Bn by 2025, expanding at a compound annual growth rate (CAGR) of ~43.98% during the 2020-2025 period. Segment insights: The e-pharmacy market in India is categorized into two segments chronic therapy and acute therapy. The market is dominated by the chronic therapy segment, which accounted for ~65% share of the overall revenue in 2019. Acute therapy is anticipated to be the fastest-growing segment, expanding at a CAGR of 49.74% during the 2020-2025 period. Consumers with chronic ailments such as cardiovascular diseases and diabetes require to procure medications frequently to pursue their long-term treatment procedure. They consider e-pharmacy as a preferred platform for purchase medicines, owing to improved accessibility, attractive discounts, and value-added services such as treatment plan and adherence management. Market insights: The e-pharmacy market in India has gained significant traction over the past two to three years; the key enablers for its momentous growth include increased penetration of the internet, rapid growth of smartphone ownership, prevalence of lifestyle disease, and government initiatives. However, the market experiences considerable challenges due to the lack of stringent regulations, concerns regarding data security, and bottlenecks in last-mile delivery. The immense growth potential of the India e-pharmacy market has attracted the entry of various health-tech start-ups, leading e-commerce companies, and traditional brick-and-mortar pharmacies in the market space. In 2020, the market witnessed the entry of leading players such as Amazon, Flipkart, and Reliance. In August 2020, Reliance Retail Ventures Limited (RRVL) stepped into the market through the acquisition of the e-pharmacy player, Netmeds. In the same month, two key e-pharmacy companies, PharmEasy and Medlife announced their merger. The entry of established companies with strong e-commerce capabilities, coupled with the consolidation trends is likely to intensify the market rivalry. Impact of COVID-19: The pandemic has emphasized the importance of e-pharmacies among its stakeholders, including sellers, consumers, medical professionals, and regulators. Consumer behavior has changed drastically during the critical period; the market witnessed rapid adoption among geriatric populations and consumers in non-metro areas. E-pharmacy companies have sharpened their business strategies to seize the growth opportunity. Partnership with hyperlocal stores, adopting a hybrid business model, and strengthening logistics and technology infrastructure are the key strategies implemented by market players. Companies covered ? Apollo Pharmacies Limited ? Medlife ? MedPlus Health Services Private Limited ? Netmeds Marketplace Limited ? 1mg ? 91Streets Media Technologies Private Limited (PharmEasy) ? Healthkart ? mCHEMIST Global Private Limited ? Medsonway Solutions Pvt Ltd ? Truemeds ...

  • Id : RNR-881862
  • Category : Pharma Healthcare
  • Pages : 71

Market insights In the past decade, the demand for vaccines has surged in India, fuelled by increased awareness of health and hygiene. Furthermore, support extended by the Indian government to enhance vaccination coverage has aggravated market growth. In terms of revenue, the vaccine market in India was valued at INR 72.44 Bn in 2019, and is estimated to reach INR 267.31 Bn by 2025, expanding at a compound annual growth rate (CAGR) of ~26.82% during the 2020-2025 period. Segment insights: The vaccine market in India is segmented into public and private vaccine sectors. In 2019, public vaccine sector, which mainly consists of vaccines procured by the Indian government, dominated the overall market holding a share of ~53.69%. Sales volume of the vaccines sold in the public segment through Universal Immunisation Programme (UIP) is much higher than that of the private segment; however, the price per dose of vaccine is higher in the private segment. The revenue of the private sector, which is also known as the domestic trade market, is anticipated to surpass the public segment by 2021. Increasing demand for multivalent vaccines such as hexavalent and pentavalent vaccines, along with vaccines for Zoonotic diseases is likely to drive the private vaccine market. Furthermore, the introduction of the COVID-19 vaccine in the coming years is anticipated to support the growth of the private vaccine market. COVID-19 vaccine progress: India being the largest vaccine producing country in the world, is actively engaged in the development and testing of COVID-19 vaccines through extensive research and innovation program. As of September 21, 2020, the Union Minister of India announced that three COVID-19 vaccine candidates are in the advanced stages of phase I, II, and III of clinical trial, and four in the advanced stages of pre-clinical trial. The three vaccines in advanced stages of clinical trial are COVAXIN by Bharat Biotec International Ltd., ZyCoV-D by Cadilla Healthcare Ltd., and Covishield or AZD1222 by Serum Institute of India Pvt. Ltd. (developed by Oxford University and AstraZeneca plc). Among these three candidates, COVAXIN and ZyCoV-D are the two indigenous vaccine candidates. Players in the vaccine market are aiming to seize the underlying opportunities of the COVID-19 vaccine market by scaling up production capacities, strengthening supply chain, and upgrading cold chain infrastructure. On the other hand, the Indian government is also preparing a road map to ensure fair and reasonable distribution of the vaccines. The government has formed a national expert group and is planning to use UIP for the COVID-19 vaccination program. Impact of COVID-19: The pandemic interrupted the routine immunization programs across the country, especially in the first quarter of FY 2021, owing to stringent lockdown measures and supply chain disruption. However, the market bounced back in the second quarter of FY 2021, with recovery in the sale of paediatric vaccines. The pandemic is expected to bring about significant changes in the Indian vaccine market, by gaining attention from investors and government agencies. It is expected to drive vaccine manufacturers to focus on research and innovation and attract the entry of biotech companies in the market. Furthermore, the projected spurt for COVID-19 vaccine demand is anticipated to bolster the involvement of contract manufacturers in the production process. Companies covered ? Cadila Healthcare Ltd. (Zydus Cadila) ? GlaxoSmithKline Pharmaceuticals Ltd. ? Panacea Biotec Ltd. ? Pfizer Ltd. ? Sanofi India Ltd. ? Bharat Biotech International Ltd. ? Indian Immunologicals Ltd. ? Merck Sharp & Dohme Corp. ? Serum Institute of India Pvt. Ltd. ? Vhb Life Sciences Ltd. ...

  • Id : RNR-881860
  • Category : Pharma Healthcare
  • Pages : 93

Market insights The thriving private healthcare sector, coupled with the expanding network of specialty hospitals is driving the healthcare information technology (IT) market in India. Healthcare IT has improved process and data management, as well as patients? experiences. In terms of revenue, the healthcare IT market in India was valued at INR 66.99 Bn in 2019, and is estimated to reach INR 98.21 Bn by 2025, expanding at a compound annual growth rate (CAGR) of ~6.46% during the 2020-2025 period. Segment insights: The healthcare IT market is segmented into IT hardware, IT services, and IT software. In 2019, the IT hardware segment dominated the market, accounting for 54.95% of the overall revenue. The computerization of basic operations such as patient registration and billing was the primary driving factor for the growth of the segment in the past decade. In terms of revenue, IT services was the second-largest segment, followed by IT software, in 2019. Outsourcing of IT services regarding implementation and maintenance of enterprise resource planning (ERP), customer relationship management (CRM), and hospital information system (HIS) has attributed to the segment?s growth. IT software is estimated to be the fastest-growing segment of the healthcare IT market, expanding at a CAGR of ~9.12% during the 2020-2025 period. Adoption of e-prescription, electronic health and medical records, and health information exchange, especially among hospitals located in tier II and tier III cities, is likely to bolster the growth of the IT software segment. Impact of COVID-19: Although various industries are trimming down their discretionary IT budget due to reduced economic activities, the healthcare industry is leveraging IT to optimize operations and productivity. Healthcare providers have embraced IT solutions to deal with the high volumes of patients while complying with social distance norms. The rapidly spreading contagion has triggered the demand for IT consulting in areas including analytics, strategy, security, and risk assessment. Furthermore, the demand for electronic health record system has proliferated to manage the gamut of COVID-19-related data generated every day. Indian healthcare providers such as Apollo Hospitals Enterprise Ltd., Medanta (The Medicity), Wockhardt Hospitals, Fortis Healthcare Ltd., and All India Institute of Medical Sciences (AIIMS) have scaled up their technical expertise in order to continue seamless business operations. Companies covered ? Wipro Ltd ? Allscripts (India) LLP ? Cerner Healthcare Solutions India Pvt. Ltd. ? Dell Technologies India Pvt. Ltd. ? Hewlett Packard Enterprise India Pvt. Ltd. ? IBM India Pvt. Ltd. ? Intel Technology India Pvt. Ltd. ? Oracle India Pvt. Ltd. ? SAP India Pvt. Ltd. ? Siemens Healthcare India Pvt. Ltd. ...

  • Id : RNR-881858
  • Category : Pharma Healthcare
  • Pages : 54

Ayurveda, the science of using herbs and other medicinal plants for healthcare, is practiced in India since ages. However, the use of Ayurvedic products has picked up recently in the country. As of 2019, around 76% of Indian households used Ayurvedic products for personal and health care. In India, Kerala and Tamil Nadu are the leading destinations for medical tourism mainly due to the growing number of Ayurvedic health centers, medication and yoga workshops, and Ayurvedic spas. Market insights: The Ayurveda industry in India was valued at INR 335 Bn in 2019 and is expected to reach a value of INR 1,042.07 Bn by 2025, expanding at a compound annual growth rate (CAGR) of ~22.15% during the FY 2020-FY 2025 period. Growing awareness regarding the benefits of Ayurvedic products and consumers? inclination towards maintaining a healthy lifestyle are the leading factors responsible for driving the growth of the Indian Ayurveda industry. Moreover, initiatives undertaken by the Indian government to encourage the use of natural and herbal products are likely to boost market growth. However, factors such as shortage of quality raw materials for the production of Ayurvedic compounds and lack of skilled personnel in the industry hinder the growth of the market. Segment insights: In terms of product usage, the Ayurveda industry in India is segmented into Ayurveda products and Ayurveda services. As of 2019, the Ayurveda products segment dominated the Ayurveda market in India, accounting for around 75% of the overall market share. In the aftermath of the pandemic, the Ayurveda services market segment is expected to witness slow growth, owing to the temporary closure of all the Ayurvedic service providing centers; it is expected to account for ~14.50% of the overall market in 2025. Impact of COVID-19: The rapid spread of the contagion prompted lockdown across the country that brought trade, manufacturing, and commerce to a standstill, radically transforming India's overall business scenario. However, the Ayurveda industry is among the few to have benefitted from the virus outbreak. The demand for Ayurvedic immunity boosting products such as Chawanprash, Giloy tablets, Giloy churna, honey, and Ashwagandha tablets has skyrocketed, in the wake of the pandemic. Furthermore, the demand for natural dietary supplements to relieve stress and strengthen immunity has increased. Thus, increasing adoption of natural products and Ayurvedic compounds for the prevention and treatment of COVID-19 have marked a positive impact on the overall industry. Companies covered: ?Dabur India Limited ?Emami Limited ?Charak Pharma Private Limited ?Herbolab India Private Limited ?Nagarjuna Herbal Concentrates Limited ?Patanjali Ayurved Limited ?Shahnaz Ayurveda Private Limited ?Shree Baidyanath Ayurved Bhawan Private Limited ?The Himalaya Drug Company ?Ananda In The Himalayas ?Ayurogashram Private Limited ?Mercure Goa Deevaya Retreat ?Somatheeram Ayurvedic Hospital and Yoga Centre Private Limited...

  • Id : RNR-881852
  • Category : Pharma Healthcare
  • Pages : 60

Market insights The increased adoption of digital strategy has disrupted the Indian healthcare industry. The growing demand for online appointment scheduling and remote consultation has fueled the growth of the mobile healthcare market in the country. In terms of revenue, the mobile healthcare market in India was valued at INR 50.95 Bn in 2019, and is estimated to reach INR 369.01 Bn by 2025, expanding at a CAGR of 37.69% during the 2020-2025 period. Segment insights: Based on type, the mobile healthcare market is segmented into mobile healthcare devices and services. Mobile healthcare services, which mainly consists of healthcare apps, is estimated to be the leading segment with a share of ~68.38% in 2025. Improved clinical outcome, coupled with quick access to medical attention, is projected to drive the demand for healthcare apps. The mobile healthcare devices segment comprises wearable and monitoring devices for checking health parameters such as blood pressure, blood glucose, oxygen saturation, and respiration. The increasing demand for monitoring devices to manage chronic disease conditions has propelled to the growth of the segment. However, consumers? preference is expected to shift from the healthcare devices to the healthcare services segment, owing to high costs of the devices, interoperability issues, and availability of similar functions on mobile applications. The healthcare services segment is estimated to expand at a CAGR of ~38.45% during the 2020-2025 period. Market influencers: The rise of digital technologies, coupled with supportive governmental policies, has fueled the growth of the mobile healthcare market in India. As per the Telecom Regulatory Authority of India (TRAI), the total number of Internet subscribers increased from 251.59 Mn in 2014 to 718.74 Mn in 2019. The emergence of corporate wellness programs is likely to play an essential role in driving market growth. Users? health data is monitored using wearable devices and healthcare apps, which allow employers to take preventive actions to reduce insurance costs. Various advantages, including patient-centric care, proactive response, improved access, and reduced cost, have bolstered the adoption of mobile healthcare to fulfil the gaps of the traditional healthcare ecosystem. However, challenges regarding poor technology infrastructure, performance, and data security have been impeding market growth. New entrants are struggling to establish their footprint in the market due to the lack of adequate knowledge and attention of policymakers, and an instable revenue model. Moreover, owing to India?s linguistic diversity, the absence of language localization becomes a challenge. As a result, the lack of multilingual communication is slowing down the adoption of mobile healthcare among consumers in the country. Impact of COVID-19: The pandemic has incited a paradigm shift in the Indian healthcare industry, with a shift of focus from cure-centric care to preventive care. Mobile healthcare plays a pivotal role in bringing the change. The pandemic has accelerated the adoption of mobile healthcare solutions, as healthcare apps and mobile healthcare devices establish a safe and connected healthcare ecosystem. Patients, healthcare providers, including doctors, hospitals, and clinics have been actively adopting mobile healthcare to combat COVID-19. The sale of mobile healthcare devices and the subscription to healthcare apps have increased sharply in the wake of the pandemic. The sale of mobile healthcare devices like pulse oximeters, blood pressure monitors, digital thermometers, and glucometers has amplified in the second quarter of 2020. On the other hand, healthcare app providers like Practo and mFine have witnessed steep rise in terms of new installation and online consultations amid the pandemic. Competitive insights The digital healthcare market in India has the presence of various emerging start-ups, experiencing intense competition from each other. The unexplored market in India offers immense opportunities to established global companies aiming to expand their footprint in India. With soaring demand for healthcare apps, public and private players are focusing on broadening their offering and improve the quality of service, in order to maintain market position. The players are aiming at scaling up their businesses and portfolios to address the high potential of the Indian digital healthcare market. Companies covered ?HealthifyMe Wellness Private Limited ?HealServ ?Lybrate India Private Limited ?Practo Technologies Private Limited ?Fitbit India Private Limited ?GOQii Technologies Private Limited ?OMRON Healthcare India Private Limited ?Roche Diabetes Care India Private Limited ?Samsung India Electronics Private Limited ?Xiaomi Technology India Private Limited...

  • Id : RNR-881846
  • Category : Pharma Healthcare
  • Pages : 56

Market insights The consumer landscape in the healthcare industry in India has evolved in recent years. The healthcare industry is experiencing a paradigm shift from volume-based care (fee-for-service healthcare, being independent of the service quality) to value-based care (healthcare providers are charged based on patients? health outcomes). Stakeholders in the Indian healthcare ecosystem are focusing on leveraging healthcare apps to make up for the inadequacies in healthcare infrastructure. Increasing focus on patient-centric care, emergence of advanced technologies, and changing business models have been crucial in driving the healthcare apps market in India. In terms of revenue, the healthcare apps market in India was valued at INR 28.94 Bn in 2019 and is estimated to reach INR 200.12 Bn by 2025, expanding at a CAGR of ~36.11% during the 2020-2025 period. Wellness management and appointment scheduling apps have gained widespread popularity. The demand for chronic disease management apps is expected to grow rapidly in the next few years. Market influencers: Digital transformation in the country, coupled with substantial support from the government has fueled the growth of the healthcare apps market in India. The digital footprint of the country has been strengthened by a swift growth in the number of mobile subscribers and Internet users in the country. As per the Telecom Regulatory Authority of India (TRAI), the total number of broadband subscribers reached 663.78 Mn in May 2020, up from 562.52 Mn in May 2019. Approximately 60% of the population is estimated to use the Internet in India by 2022. The market has been experiencing significant challenges due to the lack of awareness, security issues, and unsatisfactory app performance. Moreover, for majority of the consumers, fitness and wellness management are the primary areas of concern. They remain ignorant about the different types of healthcare apps available that address various other health issues. Furthermore, stakeholders are uncertain about the performance and efficiency of apps, owing to unavailability of clinical performance data. The limited availability of app content in regional languages also acts against the adoption of healthcare apps. Impact of COVID-19: The onset of COVID-19 has triggered a structural change in the Indian healthcare system by encouraging the use of healthcare technologies among the people. Numerous healthcare apps have been introduced by the central and state governments to combat COVID-19. These apps are being used for digital contact tracing of confirmed and potential patients, complying with quarantine guidelines, spreading of awareness, and providing updates on COVID-19 statistics and advisories. Since the outbreak of the virus, numerous healthcare apps have been launched by the central and state government authorities, which have been developed and designed by small IT companies. However, the country lacks in terms of a centralized app, owing to the presence of different administrative bodies dealing and responding to the pandemic both at the central and state levels. The major concerns regarding the existence of several apps are duplication of efforts, low penetration, and lack of data privacy. Competitive insights The highly competitive healthcare apps market in India is fragmented with the presence of various small and medium-sized players. Several non-healthcare companies, including IT and software development companies, technology companies, and app development agencies have penetrated the market. However, the market is yet in the nascent stages, and thus, players are experimenting with different business models to accomplish monetization. Among the various models, licensing, third party app development, in-app advertising, and pay-per-download have achieved significant success. Companies covered ?Curefit Healthcare Pvt. Ltd. ?DocEngage Informatics Pvt. Ltd. ?DocsApp ?HealthifyMe Wellness Pvt. Ltd. ?Infomoko Technology Pvt. Ltd. ?Kare4u Healthcare Solutions Pvt. Ltd. ?Lybrate India Private Limited ?NovoCura Tech Health Services Pvt. Ltd. (mfine) ?Portea Medical ?Practo Technologies Pvt. Ltd. ...

  • Id : RNR-881845
  • Category : Pharma Healthcare
  • Pages : 53

Market insights The healthcare sector in India has embraced digital transformation to improve quality and accessibility of healthcare services. In terms of revenue, the digital healthcare market in India was valued at INR 144.59 Bn in 2019, and is estimated to reach INR 884.50 Bn by 2025, expanding at a CAGR of 33.92% during the 2020-2025 period. Segment insights: Based on type, the market is segmented into telehealth, mHealth, electronic health records /electronic medical records (EHR/EMR), and others (remote diagnostics and healthcare analytics). The mHealth segment is estimated to dominate the market, with ~41.72% of revenue share in 2025, followed by the telehealth segment. Enhanced accessibility and convenience encouraged patients to embrace mHealth services and solutions, including healthcare apps and wearable devices. A keen focus on patient-centric healthcare services has boosted the demand for various telehealth services, including telemedicine, telecare, and teleconsulting. The EHR/EMR segment accounted for ~18.55% revenue share in 2019. Indian hospital chains such as AIIMS, Fortis Healthcare Limited, Manipal Hospitals, P D Hinduja Hospital, Ruby Hall Clinic, and Christian Medical College Vellore were the major adopters of EHR/EMR. Technology insights: Emerging technologies such as artificial intelligence (AI), machine learning, Blockchain, Internet of Things (IoT), Internet of Medical Things (IoMT), and Big Data analytics have helped in shaping the digital healthcare market. The advanced algorithm based on AI and machine learning has the potential to analyze complex medical data, and predict treatment and care plans for patients. IoT and IoMT have contributed to the growth of the digital healthcare market through the introduction of smart bands, smartwatches, smart glasses, connected medical devices for remote monitoring, and location-based trackers. Impact of COVID-19: The onset of the pandemic has accelerated the digital transformation of the Indian healthcare industry. The country has embraced digital healthcare as a major tool to access medical attention, owing to factors like nationwide lockdown, social distancing norms, and fear of virus transmission. With skyrocketing demand for digital healthcare solutions in the wake of the pandemic, market players are focusing on expanding their offering while improving the technology infrastructure. Furthermore, the government has been actively promoting the use of telemedicine lately, which has pushed market growth. On 25th March 2020, the Indian Medical Council released the guidelines for telemedicine practice, which helped in defining the scope of telehealth and telemedicine in the country. On the other hand, digital health has increasingly been playing an instrumental role in curbing the spread of the virus. Digital surveillance systems are being widely implemented for contact tracing and tracking of suspected patients. Competitive insights Emerging start-ups occupy the highly competitive Indian digital healthcare market. The unexplored market in India offers immense opportunities to established global companies, aiming to expand their footprint in India. With soaring demand, the public and private players are aiming at broadening their offering and improve the quality of service, in order to maintain market position. The players are focusing on scaling up their businesses and portfolios to address the high potential of the Indian digital healthcare market. Companies covered ?Dr. Lal PathLabs Ltd. ?DocEngage Informatics Pvt. Ltd. ?Gem3s Technologies Pvt. Ltd. ?Lybrate India Pvt. Ltd. ?NovoCura Tech Health Services Pvt. Ltd. (mfine) ?Practo Technologies Pvt. Ltd. ?Cerner Healthcare Solutions Pvt. Ltd. ?Philips India Limited ?Siemens Healthcare Pvt. Ltd. ?Wipro GE Healthcare Pvt. Ltd. ...

  • Id : RNR-881842
  • Category : Pharma Healthcare
  • Pages : 58

Preventive healthcare refers to the branch of medicine that helps in the early detection of diseases, thus allowing patients, access to prompt treatment. There are five stages of preventive healthcare ? primal prevention, primordial prevention, primary prevention, secondary prevention and tertiary prevention. Market insights: In 2019, preventive healthcare accounted for ~11% of India?s overall healthcare expenditure. The preventive healthcare market in India was valued at INR 3.71 Tn in 2019 and is expected to reach INR 14.58 by 2025, expanding at a compound annual growth rate (CAGR) of ~27.30% during the 2020-2025 period. The rise in prevalence of chronic and non-communicable ailments like hypertension, diabetes, arthritis, cancer and cardiovascular diseases, as well as the easy availability of advanced medical devices and services are driving the market to prosper. Moreover, the cost-effective nature of preventive healthcare has made it more adaptable for Indians. However, lack of awareness regarding preventive healthcare facilities among people and inadequate insurance coverage for preventive treatments are impeding market growth. Segment Insights: The preventive healthcare market in India is segmented into healthy consumption, fitness and wellness, infection prevention care, health monitoring, and wellbeing assurance segments. As of 2019, the preventive healthcare market was dominated by the healthy consumption segment, which accounted for ~26.55% of the total market revenue. The healthy consumption segment consists of nutraceuticals, healthy foods, organic skincare and other skincare products. The wellbeing assurance market is anticipated to be the fastest growing, expanding at a CAGR of ~31.91% during the forecast period. The growth can be attributed to the increasing popularity of telehealth and telemedicine services, owing to the social distancing and self-isolation norms imposed to curb the spread of COVID-19. By 2025, fitness and wellness, infection prevention care, and health monitoring segments are expected to hold ~9.30%, ~16.15% and ~22.80% shares, respectively, in terms of market revenue. COVID-19 impact analysis: The outbreak of the novel Coronavirus, followed by a long-term global lockdown has had a severe impact on the overall preventive healthcare market in India. Market segments including health monitoring devices, healthy consumption products, digital healthcare services, telehealth services and telemedicine solutions are likely to benefit amid the crisis. The surge in demand for immunity-boosting consumption products and infection-prevention products, growing anxiety regarding hospital and outpatient visits, and initiatives undertaken by the Indian government to encourage preventive healthcare are likely to accelerate market growth. The fitness and wellness segment has witnessed a significant setback due to the risk of virus transmission from social gatherings, and the imposition of social distancing norms. Companies covered ? 3M India Limited ? Amway India Enterprises Private Limited ? Fitness First India Private Limited ? HealthifyMe Wellness Private Limited ? Practo Technologies Private Limited ? Serum Institute of India Private Limited ? Svasth Life Private Limited ? GOQii Technologies Private Limited ? OMRON Healthcare India Private Limited ? Xiaomi Technology India Private Limited...

  • Id : RNR-881828
  • Category : Pharma Healthcare
  • Pages : 56

In terms of revenue and employment generation, healthcare has been one of the biggest industries in India. Kerala is one of the states in India that offers outstanding healthcare facilities. Market insights: The healthcare market in India was valued at INR 14.32 Tn in 2019 and is expected to expand at a compound annual growth rate (CAGR) of ~34.04% during the 2020-2025 period, to reach INR 65.51 Tn by 2025. The growth of the market can be attributed to the surge in demand for home healthcare devices, digital healthcare solutions and pharmaceutical products. Rise in the prevalence of chronic diseases, growing investments from public and private investors, and the emergence of advanced technologies like telehealth and telemedicine solutions are some of the major factors propelling the growth of the Indian healthcare market. Relaxation of FDI and increased government expenditure are some of the key factors to drive the healthcare market during the 2016-2020 period. However, inadequate healthcare infrastructure in India and low penetration of health insurance are impeding market growth. Segment Insights: The healthcare market in India is segmented into outpatient care centers, hospitals, pharmaceuticals, medical equipment and supplies, diagnostic services, digital healthcare, research and development, medical insurance and medical tourism. As of 2019, the healthcare market was dominated by the hospitals segment, which accounted for about 38.50% of the total market revenue. By 2025, the market share of the hospitals segment is expected to decline by ~10.55% to hold around 27.95% of the overall healthcare market revenue. During the 2020-2025 period, the digital healthcare segment is anticipated to become the fastest growing segment in the market as a result of the self-isolation norms imposed to restrain the spread of COVID-19 and the cost-benefit obtained from using digital healthcare solutions. Other segments of the market which are expected to witness high growth rate during the forecast period are the pharmaceuticals, and medical equipment and supplies segments. COVID-19 impact analysis: The outbreak of the contagion, followed by a long-term nationwide lockdown has had a severe impact on the overall healthcare market in India. The market segments that are likely to be positively impacted during the pandemic and the period thereafter are the digital healthcare segment, pharmaceuticals, medical equipment and supplies segment. The medical research and development (R&D) segment and the medical insurance segments are expected to experience a relatively short-term benefit during this crisis period. The medical R&D segment and the insurance segment are some of the least prioritized segments of the Indian healthcare industry and hence, the impact of COVID-19 on these segments are expected plunge with the diminishing effect of the pandemic. Other healthcare segments such as hospitals, medical tourism, and outpatient care centers are witnessing severe downfall in their markets due to the risk of virus transmission from social gatherings and the imposition of the social distancing norms. Companies covered ? Apollo Hospitals Enterprise Limited ? Aster DM Healthcare Limited ? Cipla Limited ? Dr. Lal PathLabs Limited ? Fortis Healthcare Limited ? Healthcare Global Enterprises Limited ? Narayana Hrudayalaya Limited ? Sun Pharmaceuticals Industries Limited ? Columbia Asia Hospitals Private Limited ? Max Healthcare Private Limited...

  • Id : RNR-881826
  • Category : Pharma Healthcare
  • Pages : 89

Home healthcare refers to the supportive and cost-effective medical assistance received at home for any kind of illness or injury. The home healthcare market in India mainly offers at-home health testing facilities, home diagnostic remedies, at-home doctor consultations and home healthcare services. Market insights: The home healthcare sector in India accounted for approximately 3.6% of India?s overall healthcare industry earning in 2019. The home healthcare market in India was valued at INR 295.70 Bn in 2019. It is expected to expand at a compound annual growth rate (CAGR) of ~18.91% during the 2020-2025 period, to reach a value of INR 1,117.29 Bn by 2025. Rise in aging population and increased prevalence of chronic ailments like hypertension, diabetes, arthritis, cancer and cardiovascular diseases are propelling the growth of the market in India. Inadequate doctor-patient ratio in the country and cost-effective nature of home healthcare services are some of the other important factors driving the market. However, the lack of adequate insurance coverage for the treatments to be conducted at home, is impeding its growth. Segment Insights: The home healthcare market is broadly segmented into home healthcare services, home healthcare devices and home healthcare solutions. As of 2019, the home healthcare market was dominated by the home healthcare service segment, which accounted for ~54.40% of the total market revenue. By 2025, the market share of the home healthcare services segment is expected to decline by ~14.40% to hold round 40% of the overall home healthcare market revenue. During the 2020-2025 period, the home healthcare solutions segment is anticipated to become the fastest growing segment of the market as a result of social distancing and self-isolation norms imposed to curb the spread of COVID-19. By 2025, the home healthcare devices and home healthcare solution segments are expected to hold ~15.70% and ~44.30% shares, respectively, in terms of market revenue. COVID-19 impact analysis: The outbreak of the Coronavirus disease, followed by a long-term global lockdown has had a severe impact on the overall home healthcare market in India. The telehealth solutions, health screening and monitoring devices, and home nursing services segments are likely to witness a significant growth amid the worldwide crisis. Perpetuation of social distancing norms, exhaustion of outdoor medical capacities, and initiatives undertaken by the Indian government to encourage at-home treatments and telehealth solutions are likely to accelerate market growth. Other home healthcare segments anticipated to be positively influenced during this period include health diagnostic devices, at-home therapeutic services and other medical supplies. Companies covered ? Apollo Home Healthcare Limited ? CallHealth Services Private Limited ? Care24 ? Critical Care Unified Private Limited ? Guardian Angel Homecare Private Limited ? Healthcare At Home Private Limited ? India Home Health Care Private Limited ? Life Circle Health Services Private Limited ? Medwell Ventures Private Limited ? Portea Medical Private Limited ? Practo Technologies Private Limited ? Lybrate India Private Limited...

  • Id : RNR-881820
  • Category : Pharma Healthcare
  • Pages : 53

With the growing population and changing lifestyle of Indians, the market for home used testing kits in the country has gained momentum over the past few years. Home testing kits that are most popularly used in India include at-home pregnancy test kits, home testing kits for fertility prediction, at-home HIV test kits, at-home blood pressure monitoring devices, glucometer and thermometer. Europe, North America and the Asia-pacific region together account for more than three-fourth of the global home testing kits market. China, India and Japan contribute significantly to the market revenue in the Asia-pacific region. Market insights: As of 2019, India accounted for about 7% of the overall revenue generated by the global home testing kits market. The home testing kits market in India was valued at INR 9.05 Bn in 2019. Further, the market is anticipated to expand at a compound annual growth rate (CAGR) of ~9.88% during the 2020-2025 period, to reach a value of INR 15.57 Bn by 2025. Rising prevalence of chronic ailments like hypertension, diabetes and cardiovascular diseases is one of the major factors propelling the growth of the market in India. Increase in disposable income, improved awareness regarding physical wellbeing among people, and easy accessibility of home testing devices in urban and semi-urban areas of the country are some of the other important factors contributing to the growth of the market. However, the lack of accuracy in test results, awareness, affordability and accessibility of these devices in rural areas is impeding the development of the industry. COVID-19 impact analysis: The worldwide outbreak of the COVID-19 pandemic, followed by a long-term nationwide and global lockdown to curb contagion proved difficult for the manufacturing and logistics sectors. As a result, the home testing kits market is anticipated to witness a breach in the demand and supply of testing devices. The market experienced an unexpected increase in the demand for home testing kits like infrared thermometer and glucometer on account of the lockdown following the outbreak. The sudden rise in demand of these devices significantly contributed to the market revenue in the first quarter of 2020. However, due to the unanticipated disruption in international trading and halt in the production of devices, the supply is expected drop in the post-lockdown period, leading to a fall in the market revenue. This scenario is expected to persist until the market stabilizes itself in a healthy business cycle, overcoming the effects of the pandemic and lockdown. Competition analysis: The home testing kits market in India is highly competitive, owing to the presence of numerous players in the market. The market is not only dominated by its existing established players like Morepen Laboratories and Mankind Pharma (Prega News) but also by a number of prominent start-ups including OMRON Healthcare India, Bright Healthcare Limited (HealthSense) and Roche Diabetes Care India (Accu-Chek). New market entrants like Bione Ventures Private Limited and CPC Diagnostics Private Limited intend to establish their roots in the market with their latest venture into the COVID-19 home screening kits. Companies covered ? Morepen Laboratories Limited ? Nectar Lifesciences Limited ? Mankind Pharma Limited ? Advacare Pharma LLP ? Swiss Precision Diagnostics GmbH ? Bright Healthcare Limited ? Nureca Private Limited ? OMRON Healthcare India Private Limited ? Roche Diabetes Care India Private Limited...

  • Id : RNR-881818
  • Category : Pharma Healthcare
  • Pages : 45

Healthcare analytics is a part of the digital healthcare system, which is technologically advanced and provides enhanced health management services using IT and effective communication tools. Though at a nascent stage in India, healthcare analytics has the potential to fill the gap between the lack of availability of clinicians and limited capacity of clinics to serve patients with the help of artificial intelligence (AI) and Big Data analytics. Healthcare analytics aims to enhance patient outcomes by assisting healthcare practitioners with the use of medical knowledge that have been memorized and analyzed by computer-enabled robotic systems, that results in an effective medical solution. It encompasses mainly three types of analytics solutions, namely descriptive analytics, predictive analytics and prescriptive analytics. Healthcare practitioners, healthcare providers, the government and pharmaceutical companies are the major end users of healthcare analytics solutions. Market insights: In 2019, healthcare analytics accounted for ~10.81% of the digital healthcare market in India. The healthcare analytics market in India is expected to reach a value of INR 47.04 Bn by 2025, expanding at a CAGR of ~20.49% during the 2020-2025 period. Factors like increased focus on collection and analysis of data from different healthcare sources for improved customer service, technological advancements and rising adoption of EHRs are expected to drive the growth of the healthcare analytics market in India. Over the past few years, the volume of data generated by healthcare organizations has increased immensely on account of the growing adoption of digital technology, Big Data and other advanced technologies. Use of descriptive analytics techniques facilitates better analysis of structured and unstructured data and generates valuable insights to make improved clinical decisions. Descriptive analytics accounted for ~75% of the total healthcare analytics market in 2019 in terms of the type of analytics used in healthcare organizations in India, followed by predictive and prescriptive analytics. It is estimated that in India (including rural and urban India), 4,300 people die every day due to poor diagnosis and wrong treatment of diseases. Healthcare analytics is expected to bring down this patient death rate by using more advanced tools for diagnosis and planning out proper treatment procedures. However, with rapid digitization, cybercrime poses a major challenge for the growth of the Indian healthcare industry at large. The healthcare sector is increasingly being beset with social engineering and email spoofing to target human nature and behaviour. Healthcare providers that adopt healthcare analytics tools and software should work together with cybersecurity companies, and identify techniques to secure EHRs and analytics applications, which are used remotely by various clinics to minimize cyber threats. Using healthcare analytics to contain the COVID-19 pandemic globally AI has emerged as a powerful tool to fight against the deadly novel coronavirus. Healthcare providers, healthcare professionals and researchers are increasingly using AI, machine learning, and natural language processing in order to track and contain coronavirus, and gain a comprehensive understanding of the ongoing pandemic, globally, as well as in India. Using predictive analytics, healthcare data scientists and researchers are analyzing patient data sets to determine hotspot areas. This would allow to recommend strategies for quarantining people to curb the contagion, and most importantly deploy and test new vaccines and drugs. ? RADLogics, a healthcare software company developing AI-powered solutions, based in Boston, has developed a data analytics platform for imaging COVID-19 infection from chest scans ? In March 2020, Qure.ai, an Indian healthcare analytics solutions providing company, launched an AI-powered virtual care platform named qScout for contact tracing and remote triaging of COVID-19 patients in India ? Apollo Hospitals Group, one of the largest chain of multi-specialty hospitals in India, has designed an AI-based Coronavirus Risk Assessment scanning app for screening and initial assessment of coronavirus patients, which is available in the form of an application, as well as on the website (https://covid.apollo247.com/) Competition analysis Most domestic healthcare analytics companies operating in India are aiming to reduce the disparity between the urban and rural healthcare scenario. Leading specialty-hospital chains in the country have collaborated with technology giants like Microsoft and IBM to leverage their AI and machine learning technologies to build healthcare analytics tools in order to provide advanced healthcare services to patients, and effectively manage their internal operations. Niramai Health Analytix Pvt. Ltd., SigTuple Technologies Pvt. Ltd., Tricog Health Services Pvt. Ltd. and Qure.ai are some of the major players operating in this market. Companies covered ? Aindra Systems ? Artificial Learning System (Artelus) ? Health Arx Technologies Pvt. Ltd. ? Niramai Health Analytix Pvt. Ltd. ? Predible Health ? Qure.ai ? SigTuple Technologies Pvt. Ltd. ? Tricog Health India Pvt. Ltd. ? IBM India Pvt. Ltd. ? Microsoft Corporation India Pvt. Ltd. ? Siemens Healthcare Pvt. Ltd. ...

  • Id : RNR-881817
  • Category : Pharma Healthcare
  • Pages : 54